John W Smither - Net Worth and Insider Trading
John W Smither Net Worth
The estimated net worth of John W Smither is at least $1 Million dollars as of 2024-11-13. John W Smither is the CFO of Arcutis Biotherapeutics Inc and owns about 133,036 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $1 Million. John W Smither is also the Director of Genelux Corp and owns about 6,920 shares of Genelux Corp (GNLX) stock worth over $20,483. Details can be seen in John W Smither's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John W Smither has not made any transactions after 2023-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John W Smither
John W Smither Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John W Smither owns 7 companies in total, including Arcutis Biotherapeutics Inc (ARQT) , Principia Biopharma Inc (PRNB) , and Sienna Biopharmaceuticals Inc (SNNAQ) among others .
Click here to see the complete history of John W Smither’s form 4 insider trades.
Insider Ownership Summary of John W Smither
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2021-03-10 | Chief Financial Officer |
| PRNB | Principia Biopharma Inc | 2019-02-19 | director |
| SNNAQ | Sienna Biopharmaceuticals Inc | 2019-01-01 | Chief Financial Officer |
 | | 2018-06-05 | director |
| | 2022-01-27 | director |
| | 2020-08-25 | director |
| | 2023-09-13 | director |
John W Smither Latest Holdings Summary
John W Smither currently owns a total of 2 stocks. Among these stocks, John W Smither owns 133,036 shares of Arcutis Biotherapeutics Inc (ARQT) as of March 10, 2021, with a value of $1 Million and a weighting of 98.52%. John W Smither also owns 6,920 shares of Genelux Corp (GNLX) as of September 13, 2023, with a value of $20,483 and a weighting of 1.48%.
Latest Holdings of John W Smither
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2021-03-10 | 133,036 | 10.25 | 1,363,619 |
| GNLX | Genelux Corp | 2023-09-13 | 6,920 | 2.96 | 20,483 |
Holding Weightings of John W Smither
John W Smither Form 4 Trading Tracker
According to the SEC Form 4 filings, John W Smither has made a total of 7 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 1,750 shares on March 10, 2021, which brought John W Smither around $57,575.
According to the SEC Form 4 filings, John W Smither has made a total of 1 transactions in Genelux Corp (GNLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Genelux Corp is the sale of 900 shares on September 13, 2023, which brought John W Smither around $18,702.
Insider Trading History of John W Smither
- 1
John W Smither Trading Performance
John W Smither Ownership Network
Ownership Network List of John W Smither
Ownership Network Relation of John W Smither
John W Smither Owned Company Details
What does Arcutis Biotherapeutics Inc do?
Who are the key executives at Arcutis Biotherapeutics Inc?
John W Smither is the Chief Financial Officer of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include director & President and CEO Todd Franklin Watanabe , See Remarks Patrick Burnett , and SVP and General Counsel Masaru Matsuda .
Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary
Over the past 18 months, John W Smither made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 119,269 shares made by Patrick Burnett , a net sale of 24,466 shares made by Masaru Matsuda , and a net sale of 60,000 shares made by Howard G. Welgus .
In summary, during the past 3 months, insiders sold 81,406 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 81,406 shares. During the past 18 months, 294,384 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 191,869 shares.
Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcutis Biotherapeutics Inc Insider Transactions
John W Smither Mailing Address
Above is the net worth, insider trading, and ownership report for John W Smither. You might contact John W Smither via mailing address: C/o Kythera Biopharmaceuticals, Inc., 27200 West Agoura Road, Suite 200, Calabasas Ca 91301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
